Vermillion, Inc.
(NASDAQ : VRML)

( )
VRML After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
0.01%90.691.3%$836.99m
AMGNAmgen Inc.
0.89%188.341.2%$659.06m
GILDGilead Sciences, Inc.
1.84%67.590.9%$528.28m
BIIBBiogen Inc.
2.51%332.871.3%$459.94m
ILMNIllumina, Inc.
2.51%299.823.5%$326.05m
REGNRegeneron Pharmaceuticals, Inc.
2.17%423.972.6%$322.32m
VRTXVertex Pharmaceuticals Incorporated
1.27%188.071.9%$269.19m
ALXNAlexion Pharmaceuticals, Inc.
2.77%129.422.0%$243.58m
AAgilent Technologies, Inc.
1.64%78.281.6%$138.30m
INCYIncyte Corporation
0.88%84.152.5%$117.93m
ALNYAlnylam Pharmaceuticals, Inc
0.60%83.539.2%$73.46m
SGENSeattle Genetics, Inc.
4.24%71.486.6%$70.53m
BLUEBluebird Bio, Inc.
2.04%137.0314.4%$66.91m
NKTRNektar Therapeutics
-2.18%41.695.5%$59.28m
MGNXMacroGenics, Inc.
3.41%21.847.2%$57.08m

Company Profile

Vermillion, Inc. engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. The company's bio-analytical solutions helps physicians diagnose, treat and improve gynecologic health outcomes for women. Vermillion was founded on December 9, 1993 and is headquartered in Austin, TX.